Assessment of flow-mediated dilation in humans

A methodological and physiological guideline

Dick H J Thijssen, Mark A. Black, Kyra E. Pyke, Jaume Padilla, Greg Atkinson, Ryan A. Harris, Beth Parker, Michael E. Widlansky, Michael E. Tschakovsky, Daniel J. Green

Research output: Contribution to journalReview article

690 Citations (Scopus)

Abstract

Endothelial dysfunction is now considered an important early event in the development of atherosclerosis, which precedes gross morphological signs and clinical symptoms. The assessment of flow-mediated dilation (FMD) was introduced almost 20 years ago as a noninvasive approach to examine vasodilator function in vivo. FMD is widely believed to reflect endothelium-dependent and largely nitric oxide-mediated arterial function and has been used as a surrogate marker of vascular health. This noninvasive technique has been used to compare groups of subjects and to evaluate the impact of interventions within individuals. Despite its widespread adoption, there is considerable variability between studies with respect to the protocols applied, methods of analysis, and interpretation of results. Moreover, differences in methodological approaches have important impacts on the response magnitude, can result in spurious data interpretation, and limit the comparability of outcomes between studies. This review results from a collegial discussion between physiologists with the purpose of developing considered guidelines. The contributors represent several distinct research groups that have independently worked to advance the evidence base for improvement of the technical approaches to FMD measurement and analysis. The outcome is a series of recommendations on the basis of review and critical appraisal of recent physiological studies, pertaining to the most appropriate methods to assess FMD in humans.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Heart and Circulatory Physiology
Volume300
Issue number1
DOIs
StatePublished - Jan 1 2011

Fingerprint

Dilatation
Guidelines
Vasodilator Agents
Signs and Symptoms
Endothelium
Blood Vessels
Atherosclerosis
Nitric Oxide
Biomarkers
Outcome Assessment (Health Care)
Health
Research

Keywords

  • Atherosclerosis
  • Cardiovascular risk
  • Endothelial function
  • Methodology
  • Recommendations
  • Shear rate
  • Vascular function

ASJC Scopus subject areas

  • Physiology
  • Physiology (medical)
  • Cardiology and Cardiovascular Medicine

Cite this

Assessment of flow-mediated dilation in humans : A methodological and physiological guideline. / Thijssen, Dick H J; Black, Mark A.; Pyke, Kyra E.; Padilla, Jaume; Atkinson, Greg; Harris, Ryan A.; Parker, Beth; Widlansky, Michael E.; Tschakovsky, Michael E.; Green, Daniel J.

In: American Journal of Physiology - Heart and Circulatory Physiology, Vol. 300, No. 1, 01.01.2011.

Research output: Contribution to journalReview article

Thijssen, DHJ, Black, MA, Pyke, KE, Padilla, J, Atkinson, G, Harris, RA, Parker, B, Widlansky, ME, Tschakovsky, ME & Green, DJ 2011, 'Assessment of flow-mediated dilation in humans: A methodological and physiological guideline', American Journal of Physiology - Heart and Circulatory Physiology, vol. 300, no. 1. https://doi.org/10.1152/ajpheart.00471.2010
Thijssen, Dick H J ; Black, Mark A. ; Pyke, Kyra E. ; Padilla, Jaume ; Atkinson, Greg ; Harris, Ryan A. ; Parker, Beth ; Widlansky, Michael E. ; Tschakovsky, Michael E. ; Green, Daniel J. / Assessment of flow-mediated dilation in humans : A methodological and physiological guideline. In: American Journal of Physiology - Heart and Circulatory Physiology. 2011 ; Vol. 300, No. 1.
@article{4c93365aca7842e094c93271f0af9773,
title = "Assessment of flow-mediated dilation in humans: A methodological and physiological guideline",
abstract = "Endothelial dysfunction is now considered an important early event in the development of atherosclerosis, which precedes gross morphological signs and clinical symptoms. The assessment of flow-mediated dilation (FMD) was introduced almost 20 years ago as a noninvasive approach to examine vasodilator function in vivo. FMD is widely believed to reflect endothelium-dependent and largely nitric oxide-mediated arterial function and has been used as a surrogate marker of vascular health. This noninvasive technique has been used to compare groups of subjects and to evaluate the impact of interventions within individuals. Despite its widespread adoption, there is considerable variability between studies with respect to the protocols applied, methods of analysis, and interpretation of results. Moreover, differences in methodological approaches have important impacts on the response magnitude, can result in spurious data interpretation, and limit the comparability of outcomes between studies. This review results from a collegial discussion between physiologists with the purpose of developing considered guidelines. The contributors represent several distinct research groups that have independently worked to advance the evidence base for improvement of the technical approaches to FMD measurement and analysis. The outcome is a series of recommendations on the basis of review and critical appraisal of recent physiological studies, pertaining to the most appropriate methods to assess FMD in humans.",
keywords = "Atherosclerosis, Cardiovascular risk, Endothelial function, Methodology, Recommendations, Shear rate, Vascular function",
author = "Thijssen, {Dick H J} and Black, {Mark A.} and Pyke, {Kyra E.} and Jaume Padilla and Greg Atkinson and Harris, {Ryan A.} and Beth Parker and Widlansky, {Michael E.} and Tschakovsky, {Michael E.} and Green, {Daniel J.}",
year = "2011",
month = "1",
day = "1",
doi = "10.1152/ajpheart.00471.2010",
language = "English (US)",
volume = "300",
journal = "American Journal of Physiology - Heart and Circulatory Physiology",
issn = "0363-6135",
publisher = "American Physiological Society",
number = "1",

}

TY - JOUR

T1 - Assessment of flow-mediated dilation in humans

T2 - A methodological and physiological guideline

AU - Thijssen, Dick H J

AU - Black, Mark A.

AU - Pyke, Kyra E.

AU - Padilla, Jaume

AU - Atkinson, Greg

AU - Harris, Ryan A.

AU - Parker, Beth

AU - Widlansky, Michael E.

AU - Tschakovsky, Michael E.

AU - Green, Daniel J.

PY - 2011/1/1

Y1 - 2011/1/1

N2 - Endothelial dysfunction is now considered an important early event in the development of atherosclerosis, which precedes gross morphological signs and clinical symptoms. The assessment of flow-mediated dilation (FMD) was introduced almost 20 years ago as a noninvasive approach to examine vasodilator function in vivo. FMD is widely believed to reflect endothelium-dependent and largely nitric oxide-mediated arterial function and has been used as a surrogate marker of vascular health. This noninvasive technique has been used to compare groups of subjects and to evaluate the impact of interventions within individuals. Despite its widespread adoption, there is considerable variability between studies with respect to the protocols applied, methods of analysis, and interpretation of results. Moreover, differences in methodological approaches have important impacts on the response magnitude, can result in spurious data interpretation, and limit the comparability of outcomes between studies. This review results from a collegial discussion between physiologists with the purpose of developing considered guidelines. The contributors represent several distinct research groups that have independently worked to advance the evidence base for improvement of the technical approaches to FMD measurement and analysis. The outcome is a series of recommendations on the basis of review and critical appraisal of recent physiological studies, pertaining to the most appropriate methods to assess FMD in humans.

AB - Endothelial dysfunction is now considered an important early event in the development of atherosclerosis, which precedes gross morphological signs and clinical symptoms. The assessment of flow-mediated dilation (FMD) was introduced almost 20 years ago as a noninvasive approach to examine vasodilator function in vivo. FMD is widely believed to reflect endothelium-dependent and largely nitric oxide-mediated arterial function and has been used as a surrogate marker of vascular health. This noninvasive technique has been used to compare groups of subjects and to evaluate the impact of interventions within individuals. Despite its widespread adoption, there is considerable variability between studies with respect to the protocols applied, methods of analysis, and interpretation of results. Moreover, differences in methodological approaches have important impacts on the response magnitude, can result in spurious data interpretation, and limit the comparability of outcomes between studies. This review results from a collegial discussion between physiologists with the purpose of developing considered guidelines. The contributors represent several distinct research groups that have independently worked to advance the evidence base for improvement of the technical approaches to FMD measurement and analysis. The outcome is a series of recommendations on the basis of review and critical appraisal of recent physiological studies, pertaining to the most appropriate methods to assess FMD in humans.

KW - Atherosclerosis

KW - Cardiovascular risk

KW - Endothelial function

KW - Methodology

KW - Recommendations

KW - Shear rate

KW - Vascular function

UR - http://www.scopus.com/inward/record.url?scp=78651308651&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78651308651&partnerID=8YFLogxK

U2 - 10.1152/ajpheart.00471.2010

DO - 10.1152/ajpheart.00471.2010

M3 - Review article

VL - 300

JO - American Journal of Physiology - Heart and Circulatory Physiology

JF - American Journal of Physiology - Heart and Circulatory Physiology

SN - 0363-6135

IS - 1

ER -